Chemotherapy Infusion Pumps Market Report 2026

Chemotherapy Infusion Pumps Market Overview

• Chemotherapy Infusion Pumps market size has reached to $5.2 billion in 2025 • Expected to grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Rising Cancer Rates To Boost Demand For Chemotherapy Infusion Pumps • Market Trend: Mindray's 'Rhythm Dose' Revolutionizes Chemotherapy Infusion with Personalized Drug Delivery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chemotherapy Infusion Pumps Market?

Chemotherapy infusion pumps are medical devices designed to deliver precise, continuous doses of chemotherapy drugs to cancer patients. They help optimize drug administration, reduce side effects, and allow for treatments to be administered over extended periods, either in a hospital or at home. The main types in the chemotherapy infusion pumps market are large volume pumps, syringe pump, elastomeric pumps, ambulatory infusion pumps, and others. Large volume chemotherapy infusion pumps are devices designed to deliver large quantities of chemotherapy drugs over an extended period. These pumps can be categorized based on their usage as disposable or reusable, and they serve various end users, such as hospitals, clinics, home care settings, and others.

What Is The Chemotherapy Infusion Pumps Market Growth Forecast?

The chemotherapy infusion pumps market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing shift toward outpatient cancer treatment, rising demand for home-based oncology care, growing focus on reducing hospital stay duration, increasing adoption of personalized chemotherapy regimens, expanding access to cancer treatment in emerging markets. Major trends in the forecast period include rising adoption of ambulatory and home-based chemotherapy delivery, increasing demand for precise and controlled drug administration, growing preference for disposable infusion pump systems, expansion of continuous chemotherapy infusion protocols, increasing focus on patient comfort and treatment adherence.

Global Chemotherapy Infusion Pumps Market Segmentation

1) By Type: Large Volume Pumps, Syringe Pump, Elastomeric Pumps, Ambulatory Infusion Pumps, Other Types 2) By Usage: Disposable, Reusable 3) By End User: Hospitals, Clinics, Home Care, Other End Users Subsegments: 1) By Large Volume Pumps: Traditional Large Volume Pumps, Volumetric Infusion Pumps 2) By Syringe Pump: Manual Syringe Pumps, Electronic Syringe Pumps 3) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps 4) By Ambulatory Infusion Pumps: Disposable Ambulatory Infusion Pumps, Reusable Ambulatory Infusion Pumps 5) By Other Types: Smart Infusion Pumps, Patient-Controlled Analgesia (Pca) Pumps

What Is The Driver Of The Chemotherapy Infusion Pumps Market?

The increasing incidence of cancer is expected to propel the growth of the chemotherapy infusion pumps market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer is fueled by factors such as lifestyle modifications, inherited genetic predispositions, and a combination of genetic mutations and environmental factors, such as smoking, radiation, chemicals, and infectious agents. Chemotherapy infusion pumps aid cancer patients by delivering precise, continuous doses of chemotherapy drugs, optimizing drug administration, and minimizing side effects. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing cancer incidence will drive the chemotherapy infusion pump industry.

Key Players In The Global Chemotherapy Infusion Pumps Market

Major companies operating in the chemotherapy infusion pumps market are Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Medtronic plc, Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Micrel Medical Devices SA, Zyno Medical LLC, Mindray Medical International Limited, Insulet Corporation, Tandem Diabetes Care Inc., CME Medical, Eitan Medical, Codan Medizinische Geräte GmbH & Co KG, SOOIL Development Co Ltd, Q‑Core Medical Ltd.

Global Chemotherapy Infusion Pumps Market Trends and Insights

Major companies operating in the chemotherapy infusion pumps market are innovating advanced technologies, such as customizable infusion rates for multiple chemotherapy drugs, to enable more personalized and precise treatment plans. Customizable infusion rates for chemotherapy infusion pumps allow healthcare providers to adjust the speed and dosage of chemotherapy drug delivery according to each patient's specific requirements. For instance, in May 2023, Mindray, a China-based medical device and solution provider, introduced an innovative infusion mode called 'Rhythm Dose' in their latest BeneFusion i/u infusion pump series. This advanced feature is specifically designed to optimize the delivery of chemotherapy drugs. It allows healthcare professionals to administer continuous intravenous infusions of multiple chemotherapy drugs at varying rates, facilitating more personalized treatment plans.

What Are Latest Mergers And Acquisitions In The Chemotherapy Infusion Pumps Market?

In November 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Intera Oncology Inc. for an undisclosed amount. With this acquisition, Boston Scientific aims to strengthen its interventional oncology portfolio by integrating Intera Oncology’s hepatic arterial infusion pump technology and expanding access to more precise, targeted, and effective cancer treatment solutions across global healthcare markets. Intera Oncology Inc. is a US-based medical device company specializing in implantable pump systems for delivering chemotherapy directly to the liver.

Regional Outlook

North America was the largest region in the chemotherapy infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Chemotherapy Infusion Pumps Market?

The chemotherapy infusion pumps market consists of sales of portable elastomeric infusion pumps, electronic infusion pumps, implantable infusion pumps, and patient-controlled analgesia (PCA) pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.